The MEA bioinformatics market is expected to grow from US$ 668.39 million in 2022 to US$ 1,470.48 million by 2028; it is estimated to grow at a CAGR of 14.0% from 2022 to 2028.

Rising Demand for Personalized Medicine To Provide Lucrative Opportunities

Personalized medicine is an emerging practice of medicine in which the genetic profile of an individual is used to lead decisions regarding the prevention, diagnosis, and treatment of a disease. The genetic profile of a patient assists doctors in precisely calculating a patient’s susceptibility to specific diseases and allows them to prescribe the patient a proper medication with reduced side effects. In personalized medicine, bioinformatics can be used to explore any possible mutations or gene variants affecting a patient’s response to a particular drug/treatment by analyzing the patient’s genome sequencing or microarray gene expression. The patient-specific medication is developed through bioinformatics tools. Bioinformatics devices may provide better conclusions at the genomic level with prior identification of infection and a better focus on treatment through improved personalized medicine. Therefore, the rising demand for personalized medicine, especially for rare diseases and cancer, is expected to provide growth opportunities for the bioinformatics market.

Market Overview

The MEA bioinformatics market is segmented into the UAE, Saudi Arabia, South Africa, and Rest of MEA. Saudi Arabia dominated the market in 2022. Saudi Arabia is the largest economy in the Middle East, and it is excelling in the growth of various research and development programs. It is home to more than 200 pharmaceutical companies actively participating in various gene-based technologies as they are end-users of genotyping products and services. Also, huge government and nongovernment investments in the R&D of biotechnology initiatives, such as the Saudi Human Genome Program, which aims to sequence 100,000 samples (normal and disease) from the Saudi population, are expected to boost the bioinformatics market in the country. For instance, in March 2019, Saudi-based biotechnology (biotech) startups incubated by Badir Biotech Incubator, under the Badir Program, raised ~$10 million in 2018 in new funding led by venture capital firms, individual investor networks, and governmental institutions. Further, Saudi Arabia is focusing on improving healthcare services, and public organizations and the government are initiating programs to enhance the development of various research activities. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia owing to the rising investment, which is helping in the timely delivery of genotyping products and services to various genetic disease patients and research institutes. Further, the government of Saudi Arabia launched the Saudi Vision 2030 program to reduce oil dependence and diversify other sectors, including healthcare, which is leading to significant development in healthcare services and a high adoption rate of advanced technologies. Moreover, medical R&D and clinical trials play an important role in improving healthcare, directly benefiting patients, and making the latest and significant pharmaceutical industry advancements that will be available and accessible to a broader pool of patients in Saudi Arabia. Thus, above discussed factors are boosting the growth of the bioinformatics market.

MEA Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)

MEA Bioinformatics Market Segmentation

The MEA bioinformatics market is segmented based on product, application, sector, and country.

Based on product, the MEA bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held the largest market share in 2022. Based on application, the MEA bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2022. Based on sector, the MEA bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2022. Based on country, the MEA bioinformatics market has been categorized into the UAE, Saudi Arabia, South Africa, and Rest of MEA. Further, Saudi Arabia dominated the market in 2022. Agilent Technologies, Inc.; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. are the leading companies operating in the MEA bioinformatics market.

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 MEA Bioinformatics Market – By Product
1.2.2 MEA Bioinformatics Market – By Application
1.2.3 MEA Bioinformatics Market – By Sector
1.2.4 MEA Bioinformatics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Bioinformatics Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion
5. MEA Bioinformatics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Funding and Investments in Bioinformatics
5.1.2 Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics
5.2 Market Restraint
5.2.1 Lack of Interoperability and Multiplatform Capabilities
5.3 Market Opportunities
5.3.1 Rising Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics
5.5 Impact Analysis
6. Bioinformatics Market – MEA Analysis
6.1 MEA Bioinformatics Market Revenue Forecast & Analysis
7. MEA Bioinformatics Market Analysis – By Product
7.1 Overview
7.2 MEA Bioinformatics Market Revenue Share by Product (2022 and 2028)
7.3 Bioinformatics Platforms
7.3.1 Overview
7.3.2 Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Knowledge Management Tools
7.4.1 Overview
7.4.2 Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
7.5 Bioinformative Services
7.5.1 Overview
7.5.2 Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8. MEA Bioinformatics Market Analysis – By Application
8.1 Overview
8.2 MEA Bioinformatics Market Revenue Share, by Application (2022 and 2028)
8.3 Genomics
8.3.1 Overview
8.3.2 Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Proteomics
8.4.1 Overview
8.4.2 Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.5 ChemoInformatics and Drug Design
8.5.1 Overview
8.5.2 ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.6 Transcriptomics
8.6.1 Overview
8.6.2 Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.7 Metabolomics
8.7.1 Overview
8.7.2 Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
9. MEA Bioinformatics Market Analysis – By Sector
9.1 Overview
9.2 MEA Bioinformatics Market Share, by Sector, 2022 and 2028, (%)
9.3 Medical Biotechnology
9.3.1 Overview
9.3.2 Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Animal Biotechnology
9.4.1 Overview
9.4.2 Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.5 Agricultural Biotechnology
9.5.1 Overview
9.5.2 Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Academics
9.6.1 Overview
9.6.2 Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
9.7 Environmental Biotechnology
9.7.1 Overview
9.7.2 Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.8 Forensic Biotechnology
9.8.1 Overview
9.8.2 Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
10. MEA Bioinformatics Market – Country Analysis
10.1 Overview
10.1.1 MEA: Bioinformatics Market, by Country, 2022 & 2028 (%)
10.1.1.1 UAE: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.1.4 UAE: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.1.1.5 UAE: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
10.1.1.1.6 Saudi Arabia: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.7 Overview
10.1.1.2 Saudi Arabia Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Saudi Arabia: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.2.2 Saudi Arabia: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.1.2.3 Saudi Arabia: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
10.1.1.3 South Africa: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.3.4 South Africa: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.1.3.5 South Africa: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
10.1.1.4 Rest of the MEA: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of the MEA Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of MEA: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.4.4 Rest of MEA: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.1.4.5 Rest of MEA: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. COMPANY PROFILES
12.1 Dassault Systèmes
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bruker Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Agilent Technologies, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Eurofins Scientific
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Illumina, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 QIAGEN
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Bioinformatics Market – Revenue and Forecast to 2028 (US$ Mn)
Table 2. UAE: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. UAE: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 4. UAE: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
Table 5. Saudi Arabia: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 6. Saudi Arabia: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 7. Saudi Arabia: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
Table 8. South Africa Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 9. South Africa: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. South Africa: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
Table 11. Rest of MEA: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 12. Rest of MEA: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 13. Rest of MEA: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Bioinformatics Market Segmentation
Figure 2. MEA Bioinformatics Segmentation, by Country
Figure 3. MEA Bioinformatics Market Overview
Figure 4. MEA Bioinformatics Market, By Product
Figure 5. MEA Bioinformatics Market, By Country
Figure 7. MEA PEST Analysis
Figure 8. MEA Bioinformatics Market Impact Analysis of Drivers and Restraints
Figure 9. MEA Bioinformatics Market – Revenue Forecast and Analysis
Figure 10. MEA Bioinformatics Market Revenue Share by Product (2022 and 2028)
Figure 11. MEA Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 12. MEA Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 13. MEA Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 14. MEA Bioinformatics Market Revenue Share, by Application (2022 and 2028)
Figure 15. MEA Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. MEA Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 17. MEA ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 18. MEA Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. MEA Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. MEA Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. MEA Bioinformatics Market Share, by Sector, 2022 and 2028 (%)
Figure 22. MEA Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. MEA Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 29. MEA Bioinformatics Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 30. MEA: Bioinformatics Market, by Country, 2022 & 2028 (%)
Figure 31. UAE: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Saudi Arabia: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. South Africa: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Rest of the MEA: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA bioinformatics market.
● Highlights key business priorities to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the MEA bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Middle East & Africa Bioinformatics Market

● Agilent Technologies, Inc.
● Bruker Corporation
● Dassault Systèmes
● Eurofins Scientific
● Illumina, Inc.    
● PerkinElmer Inc.     
● QIAGEN  
● Thermo Fisher Scientific Inc.  

At 14.0% CAGR, the MEA Bioinformatics Market is speculated to be worth US$ 1,470.48 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the MEA bioinformatics market was valued at US$ 668.39 million in 2022 and is expected to reach US$ 1,470.48 million by 2028, registering an annual growth rate of 14.0% from 2022 to 2028. Integration of artificial intelligence (AI) and machine learning in bioinformatics and rising demand for personalized medicine are the critical factors attributed to the market expansion.

Bioinformatics and AI are playing critical roles in changing and advancing the healthcare industry. In the context of bioinformatics, AI can be used to promote clinical research and analysis that can result in the design of new drugs and vaccines, the diagnosis of diseases, and even the prediction of pandemics. One example of how AI can be used in conjunction with bioinformatics is wearable tech. Consumers are already familiar with many types of wearable techs, such as fitness trackers and watches, and make personal use of the data they collect. The wearable tech provides real-time data over a period and can help track trends and identify signs of potentially fatal health issues, such as heart disease, much quicker and more accurately than spot tests conducted in laboratories. Also, genome sequencing plays a pivotal role in medical diagnostics. Machine learning empowered DNA sequencing techniques such as next-generation sequencing has made it possible for researchers to sequence human genomes within a day compared to the traditional sanger sequencing technology, which took over a decade to sequence a human genome. The integration of AI and machine learning in bioinformatics is showing the current trend in bioinformatics market.

On the contrary, lack of interoperability and multiplatform capabilities hurdles the growth of MEA bioinformatics market.

Based on product, the MEA bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held 47.4% market share in 2022, amassing US$ 316.73 million. It is projected to garner US$ 704.93 million by 2028 to expand at 14.3% CAGR during 2022–2028. Based on application, the MEA bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held 27.8% market share in 2022, amassing US$ 185.73 million. It is projected to garner US$ 412.70 million by 2028 to expand at 14.2% CAGR during 2022–2028. Based on sector, the MEA bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held 25.7% market share in 2022, amassing US$ 171.69 million. It is projected to garner US$ 393.49 million by 2028 to expand at 14.8% CAGR during 2022–2028. Based on country, the MEA bioinformatics market has been categorized into the UAE, Saudi Arabia, South Africa, and rest of MEA. Our regional analysis states that Saudi Arabia captured 46.0% market share in 2022. It was assessed at US$ 307.75 million in 2022 and is likely to hit US$ 670.01 million by 2028, exhibiting a CAGR of 13.8% during the forecast period. Key players dominating the MEA bioinformatics market are Agilent Technologies, Inc.; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. among others.

In Feb 2021, Thermo Fisher Scientific Inc. announced it has acquired cell sorting technology assets from Propel Labs, a wholly owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher’s Biosciences business. Propel Labs will continue to operate as a separate entity and serve its existing customers. In April 2021, Agilent Technologies, Inc. announced that it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.